Cognex and Breastfeeding
Before taking Cognex, breastfeeding women should talk to their healthcare providers about the potential risks. At this time, no studies have been conducted on whether the drug is passed through breast milk. Since Cognex is used for treating Alzheimer's disease, however, it is not likely that a woman of childbearing age would need to use this medication.
Currently, it is unknown if Cognex® (tacrine hydrochloride) passes through breast milk in humans. If you are breastfeeding or are thinking about breastfeeding, you should talk with your healthcare provider before taking Cognex.
No studies have been conducted on whether Cognex passes through breast milk in women. Keep in mind that Cognex is approved only for treating Alzheimer's disease, a condition that is unlikely to occur in women of childbearing age.
Also, because Cognex has not been adequately studied in any infants or children, it is not known if Cognex could have any negative effects on an infant if it does pass through breast milk.
You should talk with your healthcare provider about Cognex and breastfeeding. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, you and your healthcare provider can make a shared decision about Cognex and breastfeeding that is right for you.